课题基金 / 基金详情

IDENTIFICATION AND PREDICTION OF T-CELL EPITOPES BY USING HLA CLASS II-BINDING PEPTIDE MOTIFS

IDENTIFICATION AND PREDICTION OF T-CELL EPITOPES BY USING HLA CLASS II-BINDING PEPTIDE MOTIFS
使用 HLA II 类结合肽基序识别和预测 T 细胞表位
批准号:
06454222
负责人:
NISHIMURA Yasuharu
金额:
$4.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1996

项目摘要

项目成果

NISHIMURA Yasuharu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Recent advances in knowledge of crystal structures of MHC class II molecules has advanced understanding of the molecular basis for interactions between peptides and HLA class II molecules. Polymorphism of HLA class II molecules influences structures of peptides bound to HLA class II molecules. To elucidate mechanisms for statistical association between particular HLA class II alleles and susceptibility to autoimmune diseases, it is important to identify self peptides presented by disease-susceptible HLA class II molecules and triggering disease-causative autoreactive T cells. In this study, we tryed to identify self-peptides triggering autoimmune diseases including rheumatoid arthritis, insulin autoimmune syndrome, insulin dependent diabetes mellitus and infant-onset myasthenia gravis. Susceptibility to all of these diseases in the Japanese population are known to be strongly associated with particular HLA-DR-DQ haplotypes unique to Asians, and clinical features of some of these diseas … More es are different between Caucasians and Asians including Japanese. We investigated differences in binding-peptide motifs between disease susceptible and non-susceptible HLA class II molecules and predicted candidates of autoimmune self-peptides carrying binding-motifs to disease-susceptible HLA class II molecules. Indeed the major epitope for insulin-autoreactive CD4^+T cell was successfully identified by this strategy. We also found heterogeneity in immunogenetic background between Western type and Asian type of multiple sclerosis. Our data indicated that our strategy is useful to identify autoimmune self-peptides, and it is suggested that not only disease-susceptible HLA class II but also self-peptides causing diseases are different between Caucasians and Asians. These differences may well correlate to different clinical manifestations of diseases between the two ethnic groups. Recently it was found that T cell respose to antigen was not an on/off phenomenon, and altered T cell responses to altered peptide ligands were reported in mouse. We investigated responses of human T cell clones specific to non-self peptides to large panels of analogue peptides to find frequent alterations of T cell responses. This basic knowledg of altered human T cell responses may be useful for manipulation by altered peptide ligands of human pathogenic autoreactive T cell responses. Less
期刊论文(200)
专著(0)
科研奖励(0)
会议论文
Matsuoka,M.et al.: "ATL cells recognize self class II HLA antigens : implication to leukemogenesis." Leukemia. 9. 1338-1343 (1995)
Matsuoka,M.et al.:“ATL 细胞识别自身 II 类 HLA 抗原:对白血病发生的影响。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Murakami,S.et al.: "Binding of Ras- or p53-derived peptides to HLA-DR molecules : possible candidates of targets for tumor specific T Lymphocytes" Immunol.Letters. 49. 149-153 (1996)
Murakami,S.et al.:“Ras 或 p53 衍生肽与 HLA-DR 分子的结合:肿瘤特异性 T 淋巴细胞靶标的可能候选者”Immunol.Letters。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsushita,S.et al.: "HLA-DQ-binding peptide motifs.I.Comparative binding analysis of type II collage-derived peptides to DR an DQ molecules of rheumatoid arthritis-susceptible haplotypes" Int.Immunol.8. 757-764 (1996)
Matsushita,S.et al.:“HLA-DQ 结合肽基序。I.II 型胶原衍生肽与类风湿性关节炎易感单倍型的 DR 和 DQ 分子的比较结合分析”Int.Immunol.8。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fujisao,S.et: "Evaluation of peptide-HLA-binding by an enzyme-linked assay and its application to the detailed peptide motifs for HLA-DR9 (DRB1^*0901)." J.Immunol.Methods.(in press).
Fujisao,S.et:“通过酶联测定评估肽-HLA 结合及其在 HLA-DR9 (DRB1^*0901) 详细肽基序中的应用。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
157
    Development of new cancer immunotherapy aiming activation of both anti-tumor killer and helper T cells
    • 批准号:
      24300334
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.4万
    • 财政年份:
      2012
    • 负责人:
      NISHIMURA Yasuharu
    • 依托单位:
    Development of cellular cancer immunotherapy by using humaniPS-cell-derived dendritic cells and ideal cancer-associated antigens
    • 批准号:
      23650609
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      NISHIMURA Yasuharu
    • 依托单位:
    Investigation on the molecular mechanisms of antigen presentation and recognition.
    • 批准号:
      14370115
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.9万
    • 财政年份:
      2002
    • 负责人:
      NISHIMURA Yasuharu
    • 依托单位:
    Identification of tumor-specific antigens recognized by human T cells
    国内基金
    海外基金
    Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis